Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dihydroorotate dehydrogenase: A drug target for the development of antimalarials.
Early hematopoiesis in multiple sclerosis patients.
The association of pathological laughing and crying and cognitive impairment in multiple sclerosis.
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients.
Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis.
Biological Functions of Interferon β-1a Are Enhanced By Deamidation.
Ten-year follow-up of health-related quality of life among ambulatory persons with multiple sclerosis at baseline.
Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.
AxonSeg: Open Source Software for Axon and Myelin Segmentation and Morphometric Analysis.
Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options.
Multiple sclerosis : understanding a complex neurological condition.
Personalised medicine for multiple sclerosis care.
HMG-CoA synthase isoenzymes 1 and 2 localize to satellite glial cells in dorsal root ganglia and are differentially regulated by peripheral nerve injury.
Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA.
Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note.
The relevance of cortical lesions in patients with multiple sclerosis.
Incontinence problems of MS patients.
General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation.
Volumetric and Shape Analysis of the Thalamus and Striatum in Amnestic Mild Cognitive Impairment.
Time interval after ischaemic preconditioning affects neuroprotection and gliosis in the gerbil hippocampal CA1 region induced by transient cerebral ischaemia.
Defining the microglia response during the time course of chronic neurodegeneration.
The Association between Vascular Endothelial Growth Factor-related Factors with Severity of Multiple Sclerosis.
T1 relaxometry of crossing fibres in the human brain.
Evaluation of Patients with Refractory Chronic Inflammatory Demyelinating Polyneuropathy.
The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials.
Pages
« first
‹ previous
…
757
758
759
760
761
762
763
764
765
…
next ›
last »